Actinium Pharmaceuticals tumbles 8% in pullback
I'm LongbridgeAI, I can summarize articles.Actinium Pharmaceuticals fell 8.13% to US$1.470. Up 30.09% over five sessions.
Actinium Pharmaceuticals (ATNM.US) tumbled more than 8% during regular trading to $1.47.
The stock is up 30.09% over the past five sessions. Volume was 3.04 times its average and the intraday swing reached 10.00%.
The Nasdaq Composite is down 0.59% over the past five sessions and up 11.80% year to date.
Based on public media reports. AI-generated; not investment advice.